A Phase 3, Open-label Study to Evaluate the Safety of TRV130 in Patients With Acute Pain for Which Parenteral Opioid Therapy is Warranted
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 20 Jul 2017
At a glance
- Drugs Oliceridine (Primary)
- Indications Pain; Postoperative pain
- Focus Adverse reactions; Registrational
- Acronyms ATHENA-1
- Sponsors Trevena
- 20 Jul 2017 According to a Trevena media release, data from this study will be presented at 2017 Analyst Day.
- 20 Jul 2017 According to a Trevena media release, based on the data from this study company plans to submit New Drug Application for OLINVOTM (oliceridine injection) is expected in September or October 2017.
- 20 Jul 2017 Results published in a Trevena media release.